Another strategist chops his S&P 500 target — but for a different reason than the Goldman Sachs reduction
The reduction by Ed Yardeni, president and chief investment strategist of Yardeni Research, is notable for a few reasons, one ...
Goldman's Oppenheimer warns U.S. stock market may continue to underperform
Goldman Sachs analysts are cautioning that “confidence in the US growth story is moderating” and the U.S. stock market may continue to lag behind other global markets.
Tarsus Announces Pricing of Upsized $125.0 Million Public Offering
Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the pricing of an upsized ...
Tarsus Pharmaceuticals 2.809M share Spot Secondary priced at $44.50
The deal size was increased to $125M in common stock from $100M in common stock. Goldman Sachs, BofA, Barclays and Oppenheimer acted as joint ...
Goldman Sachs' annual culling of underperformers is coming earlier than usual this year
Goldman Sachs trims its staff, cutting what it deems to be the underperformers. This year, VPs stand to be big targets, BI ...
Reuters9d
Goldman Sachs may cut more than 1,300 employees in annual review, source says
NEW YORK, March 4 (Reuters) - Goldman Sachs (GS.N), opens new tab plans to trim its staffing by 3% to 5% in an annual ...